08H

8-chloro-1-methyl-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine

Find entries where: 08H

is present as a standalone ligand in 2 entries

Find related ligands:

Chemical Component Summary
Name	8-chloro-1-methyl-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine
Synonyms	ALPRAZOLAM
Identifiers	8-chloranyl-1-methyl-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine
Formula	C₁₇ H₁₃ Cl N₄
Molecular Weight	308.76
Type	NON-POLYMER
Isomeric SMILES	Cc1nnc2n1-c3ccc(cc3C(=NC2)c4ccccc4)Cl
InChI	InChI=1S/C17H13ClN4/c1-11-20-21-16-10-19-17(12-5-3-2-4-6-12)14-9-13(18)7-8-15(14)22(11)16/h2-9H,10H2,1H3
InChIKey	VREFGVBLTWBCJP-UHFFFAOYSA-N

Chemical Details
Formal Charge	0
Atom Count	35
Chiral Atom Count	0
Bond Count	38
Aromatic Bond Count	17

Drug Info: DrugBank

DrugBank ID	DB00404
Name	Alprazolam
Groups	approved illicit investigational
Description	Alprazolam is a triazolobenzodiazepine indicated for the treatment of anxiety and panic disorders.[L34783, L34788] It is mainly metabolized by CYP3As and so is contraindicated with CYP3A inhibitors like ketoconazole and itraconazole.[L34783, L34788] Benzodiazepine treatment should be stopped gradually by tapering down a patient's dose to avoid withdrawal symptoms.[A18125] Alprazolam's adverse effects are generally related to the sedation it can cause.[A18125] Alprazolam has been mixed with alcohol as a drug of abuse to potentiate the sedative effects of the drug which may lead to coma and death.[A18125] Alprazolam was given FDA approval on October 16, 1981.[L6148]
Synonyms	Alprazolam 8-Chloro-1-methyl-6-phenyl-4H-s-triazolo(4,3-a)(1,4)benzodiazepine
Brand Names	Apo-alpraz Alprazolam Nat-alprazolam Alprazolam Tablets 0.5mg Alprazolam Extended Release Alprazolam Tablets 0.25 Sentrazolam AM Alprazolam ER Alprazolam-0.25 Teva-alprazolam Niravam Alprazolam-0.5 Alprazolam Extended-release Xanax Ts Jamp-alprazolam Xanax XR Riva-alprazolam 0.5 mg Mylan-alprazolam Nu-alpraz Tab 0.25mg Gabazolamine-0.5 Jamp Alprazolam Nu-alpraz Tab 0.5mg Ntp-alprazolam Alprazolam Extended-Release Riva-alprazolam ALPRAZOLAM extended release Gabazolamine Riva-alprazolam 0.25 mg Ratio-alprazolam Apo-alpraz Ts Xanax Alprazolam XR Alprazolam Ts
Indication	Alprazolam is indicated for the acute treatment of generalized anxiety disorder in adults.[L34783] Alprazolam is also indicated, either as a standard or extended-release formulation, for the treatment of panic disorder with or without agoraphobia in adults.[L34783, L34788] Alprazolam may also be prescribed off-label for insomnia, premenstrual syndrome, and depression.[A177973]
Categories	Amines Anti-Anxiety Agents Benzazepines Benzene Derivatives Benzodiazepines and benzodiazepine derivatives Biogenic Amines Biogenic Monoamines Catechols Central Nervous System Agents Central Nervous System Depressants Cytochrome P-450 CYP2C9 Substrates Cytochrome P-450 CYP3A Substrates Cytochrome P-450 CYP3A4 Substrates Cytochrome P-450 CYP3A5 Substrates Cytochrome P-450 CYP3A7 Substrates Cytochrome P-450 Substrates Drugs that are Mainly Renally Excreted Ethanolamines GABA Agents GABA Modulators Heterocyclic Compounds, Fused-Ring Hypnotics and Sedatives Nervous System Neurotransmitter Agents Psycholeptics Psychotropic Drugs Tranquilizing Agents Triazolobenzodiazepines
ATC-Code	N05BA12
CAS number	28981-97-7

Drug Targets

Name	Target Sequence	Pharmacological Action	Actions
GABA(A) Receptor	MRKSPGLSDCLWAWILLLSTLTGRSYGQPSLQDELKDNTTVFTRILDRLL...	unknown	positive allosteric modulator
GABA(A) Receptor Benzodiazepine Binding Site	MRKSPGLSDCLWAWILLLSTLTGRSYGQPSLQDELKDNTTVFTRILDRLL...	unknown	ligand
Cytochrome P450 3A7	MDLIPNLAVETWLLLAVSLILLYLYGTRTHGLFKKLGIPGPTPLPFLGNA...	unknown	substrate
Cytochrome P450 3A4	MALIPDLAMETWLLLAVSLVLLYLYGTHSHGLFKKLGIPGPTPLPFLGNI...	unknown	substrate
Cytochrome P450 2C9	MDSLVVLVLCLSCLLLLSLWRQSSGRGKLPPGPTPLPVIGNILQIGIKDI...	unknown	substrate
Cytochrome P450 3A5	MDLIPNLAVETWLLLAVSLVLLYLYGTRTHGLFKRLGIPGPTPLPLLGNV...	unknown	substrate
Serum albumin	MKWVTFISLLFLFSSAYSRGVFRRDAHKSEVAHRFKDLGEENFKALVLIA...	unknown	binder
alpha1-acid glycoprotein	MALSWVLTVLSLLPLLEAQIPLCANLVPVPITNATLDQITGKWFYIASAF...	unknown	binder
View More

Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682